Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Pawinski

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
The Journal of Urology|December 1, 1996
A combined analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council randomized clinical trials for the prophylactic treatment of stage TaT1 bladder cancer. European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council Working Party on Superficial Bladder CancerA Pawinski, R Sylvester, K H Kurth, et al.
European Journal of Cancer (Oxford, England : 1990)|March 31, 2000
Phase II trial of vinorelbine in patients with advanced and/or recurrent cervical carcinoma: an EORTC Gynaecological Cancer Cooperative Group StudyC Lhommé, J B Vermorken, E Mickiewicz, et al.
British Journal of Cancer|January 1, 1997
Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patientsL Y Dirix, P B Vermeulen, A Pawinski, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1997
An EORTC phase II study of the efficacy and safety of linomide in the treatment of advanced renal cell carcinomaA Pawinski, A T van Oosterom, R de Wit, et al.
European Journal of Cancer (Oxford, England : 1990)|September 1, 1995
High dose epirubicin is effective in measurable metastatic prostate cancer: a phase II study of the EORTC Genitourinary GroupM Brausi, W G Jones, S D Fosså, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 1999
Vascular endothelial growth factor measured in platelet poor plasma allows optimal separation between cancer patients and volunteers: a key to study an angiogenic marker in vivo?W Wynendaele, R Derua, M F Hoylaerts, et al.
European Journal of Gynaecological Oncology|January 1, 1995
High-dose epirubicin in platinum-pretreated patients with ovarian carcinoma: the EORTC-GCCG experienceJ B Vermorken, A Kobierska, M E van der Burg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 1996
Oral ifosfamide/mesna versus intravenous ifosfamide/mesna in non-small-cell lung cancer: a randomized phase II trial of the EORTC lung cancer cooperative groupC Manegold, P Drings, A Pawinski, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
The Journal of Urology|December 1, 1996
A combined analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council randomized clinical trials for the prophylactic treatment of stage TaT1 bladder cancer. European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council Working Party on Superficial Bladder CancerA Pawinski, R Sylvester, K H Kurth, et al.
European Journal of Cancer (Oxford, England : 1990)|March 31, 2000
Phase II trial of vinorelbine in patients with advanced and/or recurrent cervical carcinoma: an EORTC Gynaecological Cancer Cooperative Group StudyC Lhommé, J B Vermorken, E Mickiewicz, et al.
British Journal of Cancer|January 1, 1997
Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patientsL Y Dirix, P B Vermeulen, A Pawinski, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1997
An EORTC phase II study of the efficacy and safety of linomide in the treatment of advanced renal cell carcinomaA Pawinski, A T van Oosterom, R de Wit, et al.
European Journal of Cancer (Oxford, England : 1990)|September 1, 1995
High dose epirubicin is effective in measurable metastatic prostate cancer: a phase II study of the EORTC Genitourinary GroupM Brausi, W G Jones, S D Fosså, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 1999
Vascular endothelial growth factor measured in platelet poor plasma allows optimal separation between cancer patients and volunteers: a key to study an angiogenic marker in vivo?W Wynendaele, R Derua, M F Hoylaerts, et al.
European Journal of Gynaecological Oncology|January 1, 1995
High-dose epirubicin in platinum-pretreated patients with ovarian carcinoma: the EORTC-GCCG experienceJ B Vermorken, A Kobierska, M E van der Burg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 1996
Oral ifosfamide/mesna versus intravenous ifosfamide/mesna in non-small-cell lung cancer: a randomized phase II trial of the EORTC lung cancer cooperative groupC Manegold, P Drings, A Pawinski, et al.
Pageof 2